Emerging data suggest Retatrutide , a dual agonist targeting both GLP-1 and GIP , may represent a promising advancement for weight treatment. Initial patient trials have indicated substantial reductions https://karimjbzj018739.mysticwiki.com/2303811/a_retatru_tide_peptide_a_innovation_in_weight_control